ChemicalBook > CAS DataBase List > Lusutrombopag

Lusutrombopag

Product Name
Lusutrombopag
CAS No.
1110768-00-7
Chemical Name
Lusutrombopag
Synonyms
Lusutrombopag;Lusutrombopag Impurity 6;(S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid;(S,E)-Ethyl 3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylate;Ethyl (S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylate;ethyl (S)-(E)-3-(2,6-dichloro-4-{4-[2-methyloxy-3-(1-hexyloxyethyl)phenyl]thiazol-2-ylcarbamoyl}phenyl)-2-methylacrylate;(S)-ethyl 3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylate(WXG02540);2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, ethyl ester, (2E)-
CBNumber
CB62756507
Molecular Formula
C31H36Cl2N2O5S
Formula Weight
619.6
MOL File
1110768-00-7.mol
More
Less

Lusutrombopag Property

Melting point:
184 - 186°C
Density 
1.246±0.06 g/cm3(Predicted)
storage temp. 
Refrigerator, under inert atmosphere
solubility 
Chloroform (Slightly), DMSO (Slightly)
form 
Solid
pka
6.30±0.50(Predicted)
color 
White Off-White
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Lusutrombopag Chemical Properties,Usage,Production

Description

Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist developed by Shionogi for improvement of thrombocytopenia associated with chronic liver disease in patients undergoing an elective invasive procedure (e.g., liver biopsy, liver transplantation). Thrombocytopenia, which is common among patients with chronic liver disease, increases the risk of bleeding when undergoing invasive procedures, which in turn complicates therapy and increases the risk of mortality. Lusutrombopag, which was approved in Japan in September 2015, promotes platelet production by stimulating the proliferation and differentiation of human bone marrow progenitor cells into megakaryocytes via the thrombopoietic pathway. The consequent increase in platelet levels avoids postponement of invasive procedures or transfusion of platelets and administration of platelet products, the current standard of care for thrombocytopenia in these patients.

Uses

Lusutrombopag is a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP.

Synthesis

To date, only two synthetic routes to lusutrombopag have been reported: one in the Japanese patent literature which has been exemplified on kilogram scale and the other a closely related discovery route which has been reported in the United States patent literature. Commercial 2,6-dibromoanisole (106) was treated with isopropylmagnesium chloride to form the corresponding Grignard reagent prior to reaction with Weinreb amide 107, furnishing a ketone which underwent immediate reduction with formic acid in the presence of chiral catalyst RuCl(p-cymene)[(S,S)-Ts-DPEN] (108) and generate the desired (S)-stereogenic alcohol 109.

Unfortunately, neither the yield nor the stereoselectivity of this reduction was reported in any of the disclosures. Benzyl alcohol 109 was subjected to Williamson etherification conditions with n-hexyl bromide to furnish ether 110. The aryl bromide within 110 was then converted to the corresponding Grignard reagent, which was reacted with N-methyloxy-N-methyl-2-chloroacetamide (111), followed by subsequent treatment with thiourea in toluene/ ethanol at elevated temperatures to give aminothiazole intermediate 112 in 45% yield across the two-step sequence. Next, activation of acid 113 prior to exposure to 112 facilitated amide bond formation. Saponification of the pendant ester with sodium hydroxide furnished luxutrombopag (XIV) in 89% yield. Although acid 113 is not commercial, it could be prepared from 3,5-dichlorobenzoic acid (33) via formylation with 4-formylmorpholine, followed by a Horner-Wadsworth-Emmons reaction with triethylphosphonopropionate.

Lusutrombopag Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lusutrombopag Suppliers

Shanghai Feibo Chemical Technology Co., Ltd
Tel
021-58955608,2250286 15921236618
Email
blinkzeng@gmail.com
Country
China
ProdList
523
Advantage
62
Shanghai T&W Pharmaceutical Co., Ltd.
Tel
+86 21 61551611
Fax
+86 21 50676805
Country
China
ProdList
9900
Advantage
58
Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Fax
028-81705658
Email
3003855609@qq.com
Country
China
ProdList
7892
Advantage
56
Shanghai Synchem Pharma Co., ltd
Tel
21-619849051-1 18521059765
Email
synchempharma@aliyun.com
Country
China
ProdList
6456
Advantage
55
ShangHai Biochempartner Co.,Ltd
Tel
17754423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8011
Advantage
62
Chuzhou KeMail Chemical Technology Co., Ltd
Tel
0550-5196001 15000891977
Fax
0550-5196001
Email
wj520wjxby@126.com
Country
China
ProdList
1836
Advantage
55
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471 +1-2135480471
Email
sales@sarms4muscle.com
Country
China
ProdList
10523
Advantage
58
AFINE CHEMICALS LIMITED
Tel
+86-0571-85134551
Fax
008657185134895
Email
info@afinechem.com
Country
China
ProdList
15396
Advantage
58
Shanghai Yanze Chemical Co., Ltd.
Tel
021-13773155751 19901447308
Email
260924549@qq.com
Country
China
ProdList
8756
Advantage
58
Shenzhen ruikai de biotechnology co., ltd.
Tel
0755-61348847 17820674378
Fax
0755-21016893
Email
2682116078@qq.com
Country
China
ProdList
7844
Advantage
58
career henan chemical co
Tel
+86-0371-86658258 15093356674;
Fax
0086-371-86658258
Email
factory@coreychem.com
Country
China
ProdList
29826
Advantage
58
Wuhan Yanzhe Technology Co., Ltd
Tel
15527250409
Fax
QQ:2692360204
Email
wenhaotian12@163.com
Country
China
ProdList
4576
Advantage
58
Molcoo Chemicals Inc.
Tel
18627923403 18627753421
Email
3001006472@qq.com
Country
China
ProdList
8749
Advantage
58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd
Tel
18162595016
Email
3287908757@qq.com
Country
China
ProdList
9887
Advantage
58
Qingdao Ruifengyuan Chemical Co., Ltd.
Tel
13375559818 13375559818
Email
cfy69@163.com
Country
China
ProdList
259
Advantage
58
Dongying Sifang Litong New Material Co. LTD
Tel
13589435123 17861826421
Email
dysflt@126.com
Country
China
ProdList
286
Advantage
58
Henan Fengda Chemical Co., Ltd
Tel
+86-371-86557731 +86-13613820652
Fax
86-0371-86557731
Email
info@fdachem.com
Country
China
ProdList
20393
Advantage
58
Qingdao Minzhi Yijie new material Co., LTD
Tel
+86-13589435123 +86-13589435123
Email
qdmzyj@126.com
Country
China
ProdList
240
Advantage
58
Guangzhou Weijia Technology Co., Ltd.
Tel
--
Fax
--
Email
WHIGA22@126.COM
Country
CHINA
ProdList
6748
Advantage
58
Boao Pike
Tel
--
Fax
--
Email
lyn@biopike.com.cn
Country
CHINA
ProdList
6629
Advantage
58
Shanghai Han-Xiang Chemical Co., Ltd.
Tel
--
Fax
--
Email
kexianxun@gmail.com
Country
China
ProdList
1039
Advantage
50
More
Less

View Lastest Price from Lusutrombopag manufacturers

Career Henan Chemical Co
Product
(S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid 1110768-00-7
Price
US $1.00/KG
Min. Order
1KG
Purity
97%-99.9%
Supply Ability
100kg
Release date
2019-12-26

1110768-00-7, LusutrombopagRelated Search:


  • (S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid
  • Lusutrombopag
  • (S)-ethyl 3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylate(WXG02540)
  • ethyl (S)-(E)-3-(2,6-dichloro-4-{4-[2-methyloxy-3-(1-hexyloxyethyl)phenyl]thiazol-2-ylcarbamoyl}phenyl)-2-methylacrylate
  • 2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, ethyl ester, (2E)-
  • Lusutrombopag Impurity 6
  • Ethyl (S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylate
  • (S,E)-Ethyl 3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylate
  • 1110768-00-7
  • 1110767-97-6
  • 1110767-00-7
  • C31H36Cl2N2O5S